This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignees: Biorec S.a., Centro De Ingenieria Genetica Y Biotechnologia. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 4 
1 out of 15 Years Active: 2016
Title: Lincidio Perez Sanchez: Innovator in Recombinant Antibodies
Introduction
Lincidio Perez Sanchez is a notable inventor based in La Habana, Cuba. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant antibodies. His work focuses on addressing critical health issues through innovative solutions.
Latest Patents
Lincidio Perez Sanchez holds a patent for "Recombinant antibodies to the vascular endothelial growth factor (VEGF) which are obtained by means of mutagenesis of variable regions." This invention reveals human recombinant antibodies that recognize the human Vascular Endothelium Growth Factor A (VEGF-A). These antibodies block the interaction with the VEGFR2 receptor and interfere with its proliferative effect in vitro and pro-angiogenic effect in vivo. The antibodies identify a unique epitope on human VEGF-A, different from any previously reported. They were obtained by combining one immunoglobulin light chain variable region with three heavy chain ones. The antibodies can be employed for immunotherapy of pathological entities associated with increased vasculature, such as age-related macular degeneration and cancer.
Career Highlights
Throughout his career, Lincidio Perez Sanchez has worked with prominent organizations in the biotechnology sector. He has been associated with the Centro de Ingeniería Genética y Biotecnología and Biorec S.A. His work has significantly impacted the development of therapeutic solutions in the medical field.
Collaborations
Lincidio has collaborated with notable individuals in his field, including Humberto Lamdan Ordas and Jorge Victor Gavilondo Cowley. These collaborations have contributed to the advancement of his research and innovations.
Conclusion
Lincidio Perez Sanchez is a pioneering inventor whose work in recombinant antibodies has the potential to transform therapeutic approaches to various diseases. His contributions to biotechnology highlight the importance of innovation in addressing global health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile